While the public may assume that all the genes in the human genome have been identified, Neomorphic Inc. see ample business opportunity in its predictive and analytical technologies to locate and identify human genes.

"The genome isn't done, it's evolving. A sequence that's 99.9 percent correct means 1 in 1000 errors - that's not great," said President and CEO Cyrus Harmon.